TPST: Tempest Therapeutics Inc
今日TPST汇率已更改2.64%。当日,交易品种以低点2.62和高点2.78进行交易。
关注Tempest Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TPST新闻
- Tempest Therapeutics收到纳斯达克年度股东大会合规通知
- Tempest Therapeutics receives Nasdaq notice for annual meeting compliance
- Tempest Therapeutics完成425万美元的注册直接发行
- Tempest Therapeutics closes $4.25 million registered direct offering
- Tempest Therapeutics股价在425万美元直接融资后下跌
- Tempest Therapeutics stock falls after $4.25 million direct offering
- Tempest Therapeutics raises $4.25 million in registered direct offering
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%
- 美国股市上涨;截至收盘道琼斯工业平均指数上涨0.10%
- Tempest Therapeutics股价在全股票收购后暴跌
- Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs
- Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results - Agios Pharmaceuticals (NASDAQ:AGIO), Carver Bancorp (NASDAQ:CARV)
- Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast - Freight Technologies (NASDAQ:FRGT), Carver Bancorp (NASDAQ:CARV)
- Why Tempest Therapeutics (TPST) Stock Is Down 45% Today - Tempest Therapeutics (NASDAQ:TPST)
- Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
- How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
- Tempest gets NMPA approval for pivotal trial of liver cancer drug
- Tempest Therapeutics ends ATM prospectus with Jefferies
- Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Circle Internet Group (NYSE:CRCL), Davis Commodities (NASDAQ:DTCK)
- Tempest Therapeutics stock rises on EMA Orphan Drug Designation
- Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
- Tempest Therapeutics stock rises on FDA Orphan Drug Designation
- Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success - Tempest Therapeutics (NASDAQ:TPST)
常见问题解答
TPST股票今天的价格是多少?
Tempest Therapeutics Inc股票今天的定价为2.72。它在2.62 - 2.78范围内交易,昨天的收盘价为2.65,交易量达到180。TPST的实时价格图表显示了这些更新。
Tempest Therapeutics Inc股票是否支付股息?
Tempest Therapeutics Inc目前的价值为2.72。股息政策取决于公司,而投资者也会关注205.62%和USD。实时查看图表以跟踪TPST走势。
如何购买TPST股票?
您可以以2.72的当前价格购买Tempest Therapeutics Inc股票。订单通常设置在2.72或3.02附近,而180和1.87%显示市场活动。立即关注TPST的实时图表更新。
如何投资TPST股票?
投资Tempest Therapeutics Inc需要考虑年度范围0.41 - 12.22和当前价格2.72。许多人在以2.72或3.02下订单之前,会比较-5.88%和。实时查看TPST价格图表,了解每日变化。
Tempest Therapeutics Inc股票的最高价格是多少?
在过去一年中,Tempest Therapeutics Inc的最高价格是12.22。在0.41 - 12.22内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Tempest Therapeutics Inc的绩效。
Tempest Therapeutics Inc股票的最低价格是多少?
Tempest Therapeutics Inc(TPST)的最低价格为0.41。将其与当前的2.72和0.41 - 12.22进行比较,可以发现潜在的长期切入点。观看TPST在图表上的实时走势以获取更多详细信息。
TPST股票是什么时候拆分的?
Tempest Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、2.65和205.62%中可见。
- 前一天收盘价
- 2.65
- 开盘价
- 2.67
- 卖价
- 2.72
- 买价
- 3.02
- 最低价
- 2.62
- 最高价
- 2.78
- 交易量
- 180
- 日变化
- 2.64%
- 月变化
- -5.88%
- 6个月变化
- -61.96%
- 年变化
- 205.62%
- 实际值
- 预测值
- 前值